All articles by vemula pravalika
vemula pravalika
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Respiratory Panel Plus syndromic test for clinical use.
CLEW Medical Secures FDA Clearance for Second-Generation AI Models
Advancing Predictive Patient Deterioration Technology with Superior Accuracy
CardiodiagnosticsTests at Walmart Clinic – Walk-Ins, Seven Days/Week
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood tests, Epi+Gen CHD and PrecisionCHD, are now available at Family Medicine Specialists’ (FMS) newest clinical location at the Walmart Supercenter in Round Lake Beach, Illinois. FMS is a leading primary care and risk-bearing provider in Northern Illinois and in December 2023, launched the ongoing Heart Attack Prevention Initiative for at least 1,200 of their BlueCross BlueShield and other health plan patients. This launch in a retail healthcare setting is an expansion to existing and new patients in the area.
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc.
Ecolab and HeiQ introduce synbiotic cleaning products at Interclean
Ecolab and HeiQ Chrisal have teamed up to launch the revolutionary Maxx Synbiotic cleaning range at Interclean in Amsterdam, The Netherlands.
MolecuLight’s Innovative Approach Awarded Best Abstract at EWMA 2024
MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, is proud to announce that a groundbreaking study led by Dr. Rosemarie Derwin and colleagues, titled “Integrating Point-of-Care Bacterial Fluorescence Imaging-Guided Care with Continued Wound Measurement for Enhanced Wound Area Reduction Monitoring,” has been awarded Best Abstract of the Year at the prestigious European Wound Management Association (EWMA) conference held in London, UK this May 2024.
Biofortuna completes acquisition of biological sample storage experts Cryoniss
Biofortuna Limited, the specialist laboratory services and CDMO, has completed the acquisition of Cryoniss Ltd, underlining its commitment to support life-changing research and development across the global biotech and life sciences sector.
Inside the oxygen paradox
In recent years, a number of studies have found that conservative, normoxic oxygenation strategies could yield certain benefits and can help reduce mortality. Recently, a study conducted by researchers at UCL and Great Ormond Street Hospital has found similar findings with reduced oxygen levels in critically ill children on mechanical ventilators potentially saving tens of young lives each year. Roughly 20,000 children are admitted to intensive care each year; with three-quarters requiring oxygen through a ventilator, how can reduced oxygen result in improved health outcomes? Monica Karpinski speaks to associate professor of medicine and critical care physician at Vanderbilt University Medical Centre, Matthew Semler and Mark Peters professor of paediatric intensive care at University College London Great Ormond Street Institute of Child Health to investigate the latest research to fi nd out whether reduced oxygen could help save lives.
The mind’s AI
Brain tumour classification is notoriously tricky. While there are more than 80 different subtypes of brain tumour, each with its own best course of treatment, the diagnosis doesn’t usually become available until a week after surgery. However, surgeons may now be able to alter their strategy in real-time, thanks to a new deep-learning algorithm that classifies tumours in hours, not days. Abi Millar talks to the researchers to find out more.
Protein potential
A team of researchers at QUT in Australia has developed a new approach for designing molecular ON-OFF switches based on proteins, which could eventually lead to a modular diagnostic platform with countless applications. Elly Earls sat down with one of the researchers behind the breakthrough, Professor Kirill Alexandrov of the QUT School of Biology and Environmental Science, to find out how their system works, its potential to scale and why synthetic protein switches for diagnostic applications could just be a precursor to something a lot more exciting.